1-40072769-ACTT-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_000310.4(PPT1):c.*1289_*1291delAAG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00725 in 152,254 control chromosomes in the GnomAD database, including 10 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0073 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PPT1
NM_000310.4 3_prime_UTR
NM_000310.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.878
Genes affected
PPT1 (HGNC:9325): (palmitoyl-protein thioesterase 1) The protein encoded by this gene is a small glycoprotein involved in the catabolism of lipid-modified proteins during lysosomal degradation. The encoded enzyme removes thioester-linked fatty acyl groups such as palmitate from cysteine residues. Defects in this gene are a cause of infantile neuronal ceroid lipofuscinosis 1 (CLN1, or INCL) and neuronal ceroid lipofuscinosis 4 (CLN4). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00725 (1104/152254) while in subpopulation AFR AF= 0.0256 (1063/41530). AF 95% confidence interval is 0.0243. There are 10 homozygotes in gnomad4. There are 519 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPT1 | NM_000310.4 | c.*1289_*1291delAAG | 3_prime_UTR_variant | 9/9 | ENST00000642050.2 | NP_000301.1 | ||
PPT1 | NM_001363695.2 | c.*1289_*1291delAAG | 3_prime_UTR_variant | 8/8 | NP_001350624.1 | |||
PPT1 | NM_001142604.2 | c.*1289_*1291delAAG | 3_prime_UTR_variant | 6/6 | NP_001136076.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00725 AC: 1103AN: 152136Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
1103
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 54Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 34
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
54
Hom.:
AF XY:
AC XY:
0
AN XY:
34
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00725 AC: 1104AN: 152254Hom.: 10 Cov.: 32 AF XY: 0.00697 AC XY: 519AN XY: 74448
GnomAD4 genome
AF:
AC:
1104
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
519
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neuronal Ceroid-Lipofuscinosis, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at